Jobs at Roivant

Our two-year Rotational Analyst Program begins in July 2027. It offers recent college graduates the opportunity to complete four (4) six-month rotations across different teams and functions, including our portfolio of Vants. The aim of this program is to attract and develop future leaders across the Roivant family by accelerating the development of talent. From day one, analysts will own projects and have opportunities to make a meaningful impact. Now in its seventh year, Rotational Analysts have taken on demanding projects across a wide range of functions at Roivant and the Vants.

• Evaluate in-licensing opportunities to expand Roivant’s portfolio of life-changing medicines.
• Perform literature reviews to identify indication expansion opportunities in support of Vants.
• Develop strategies to accelerate clinical trial recruitment.
• Create investor decks in partnership with key executives for Phase 3 clinical trial readouts.
• Own projects and contribute meaningfully across different teams and functions.
• Collaborate across teams to solve challenging healthcare problems.

• Enrolled in a 4-year undergraduate university in the United States with an expected graduation date between December 2026 and June 2027, as this program begins July 2027.
• Currently pursuing an undergraduate degree in the life sciences, business, economics, or a related quantitative field (e.g., Biology, Chemistry, Biochemistry, Economics, Finance, Data Science, Public Health), with demonstrated interest or experience in healthcare, biotech, or the life sciences.

Requirements: 

• Track record of academic excellence; GPA of 3.5 or higher.
• Willingness to relocate to New York, NY.
• Authorization to work in the U.S. This role is not eligible for visa sponsorship including STEM-OPT.